MENU
Advertisement
Show Filters
Refine by Content Type
Refine by Year
Sort By:
Choose Sites to Search:
Lotus Valve
A look at the future of percutaneous valve replacement.
By Ian T. Meredith, MBBS, PhD; Kristin L. Hood, PhD; Dominic J. Allocco, MD; and Keith D. Dawkins, MD
Protembis Financing Will Support ProtEmbo Cerebral Protection System’s Pivotal Trial
March 26, 2024—Protembis GmbH, a privately-held emerging cardiovascular medical device company based in Aachen, Germany, announced the completion of a €30 million Series B financing round to support the enrollment of the PROTEMBO investigational device exemption (IDE) pivotal trial of the ProtEmbo cerebral protection system.
Financing Will Support FIH Clinical Evaluation of InnovHeart’s Saturn TMVR System
August 7, 2020—InnovHeart s.r.l., a developer of transcatheter mitral valve replacement (TMVR) systems for the treatment of mitral valve disease, announced the closing of a €20 million round of equity financing.
InnovHeart Raises Financing to Develop Saturn Transseptal TMVR System
January 27, 2022—InnovHeart s.r.l., a developer of transcatheter mitral valve replacement (TMVR) systems for the treatment of mitral valve disease, announced the closing of its Series C financing with the granting of an exclusive licensing agreement to Grand Pharmaceutical Group Limited (Grand Pharma) for InnovHeart’s Saturn device in Greater China.
Aortic Valve Update
By Ted E. Feldman, MD, FSCAI, Chief Medical Editor
Highlights from EuroPCR
DES, COURAGE, and the Great Debate
Does the Metal Matter?
An overview of next-generation stent platforms.
By Louis A. Cannon, MD, Fscai, FACC, FACP; Gary A. Daniel, MD; Kristin L. Hood, PHD; and Steven J. Yakubov, MD, FACC
